02.18.21

Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia

Source: Ocuphire Pharma

01.20.21

Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol

01.06.21

Ocuphire Completes Enrollment in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol for Reversal of Mydriasis

Source: Ocuphire Pharma

01.05.21

Ocuphire Pharma Initiates LYNX-1 Phase 3 Study Investigating Nyxol in Night Vision Disturbances

Source: Ocuphire Pharma

11.07.19

Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol Eye Drops

Source: Ocuphire Pharma

07.23.19

Ocuphire Pharma Raises Over $5 Million to Complete Late Phase 2 Clinical Trials for Ophthalmic Disorders

Source: Ocuphire Pharma

View more stories